Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Immunitybio Inc (NQ: IBRX )

1.640 +0.180 (+12.33%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,970,454
Open 1.440
Bid (Size) 1.630 (2)
Ask (Size) 1.650 (34)
Prev. Close 1.460
Today's Range 1.390 - 1.690
52wk Range 1.210 - 7.800
Shares Outstanding 391,156,513
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Why Citi Trends Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers U.S. Xpress Enterprises, Inc. (NYSE: USX) shares surged 298% to $5.97 after Knight-Swift Transportation agreed to acquire the company for $6.15 per share. 
Via Benzinga

Performance

YTD
-65.62%
-65.62%
1 Month
-41.64%
-41.64%
3 Month
-69.96%
-69.96%
6 Month
-66.05%
-66.05%
1 Year
-72.62%
-72.62%

More News

Read More
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
ImmunityBio to Present ‘Quality of life in QUILT 3.032 study: Patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) receiving IL-15R⍺Fc superagonist N-803 plus BCG’ at ASCO GU
From ImmunityBio, Inc.
Via Business Wire
Why Sabre Are Trading Lower By 19%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
ImmunityBio Announces Execution of $50 Million Equity Financing with Multiple Institutional Investors
From ImmunityBio, Inc.
Via Business Wire
ImmunityBio Announces Presentation at ASCO GI 2023 of Fully Enrolled Trial in Third-Line and Greater Pancreatic Cancer and Update on FDA Type B Meetings Regarding Paths to Registration
From ImmunityBio, Inc.
Via Business Wire
Tesla, Hyzon Motors And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Via Benzinga
ImmunityBio Announces $157 Million Financing From Nant and Institutional Investor
From ImmunityBio, Inc.
Via Business Wire
ImmunityBio to Participate in 34th Annual Piper Sandler Healthcare Conference
From ImmunityBio, Inc.
Via Business Wire
NEJM Evidence Publishes Results for ImmunityBio’s QUILT 3.032 Registrational Trial of IL-15 Superagonist N-803 Plus BCG in Patients with Bladder Cancer
From ImmunityBio
Via Business Wire
ImmunityBio to Participate in the Jefferies London Healthcare Conference
From ImmunityBio, Inc.
Via Business Wire
Worthington Industries, CarMax And Other Big Losers From Thursday
Via Benzinga
7 Unknown Biotech Stocks That Could Rocket in 2023
Via InvestorPlace
Nikola, Super Micro Computer And Other Big Losers From Monday
Via Benzinga
Twilio, AMTD Digital And Other Big Gainers From Wednesday
Via Benzinga
Why KnowBe4 Shares Jumped Over 28%; Here Are 79 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Virios Therapeutics Is Trading Lower By Over 71%, Here Are 55 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why Hill International Is Trading Higher By 15%; Here Are 30 Stocks Moving Premarket
Via Benzinga
Why Adobe Is Trading Lower By 17%, Here Are 49 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2022
Via Benzinga
Why Vintage Wine Estates Shares Tumbled 40%; Here Are 70 Biggest Movers From Yesterday
Via Benzinga
Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.